Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma. 1982

M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene

Biologic activities and immunochemical characteristics of an azobenzenearsonate- (ABA)specific suppressor T cell factor produced by a longterm T cell hybridoma, F12, were studied. In vivo administration of F12 culture supernatant resulted in the suppression of ABA-specific delayed-type hypersensitivity (DTH) responses and the inhibition of priming for ABA-specific cytotoxic T lymphocyte responses. Moreover, F12 induced a second set of suppressor cells that act in the efferent phase of DTH. The active material in the F12 culture supernatant expressed major cross-reactive idiotypic (CRI) determinants of anti-ABA antibodies of A/J mice and I-J subregion-coded specificities but not express determinants of immunoglobulin constant regions. These results demonstrated that F12 is a functioning hybrid cell line of the first-order suppressor T cell subset.

UI MeSH Term Description Entries
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D008806 Mice, Inbred AKR An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mice, AKR,Mouse, AKR,Mouse, Inbred AKR,AKR Mice,AKR Mice, Inbred,AKR Mouse,AKR Mouse, Inbred,Inbred AKR Mice,Inbred AKR Mouse
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010132 p-Azobenzenearsonate A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool. Azophenylarsonate,para-Azobenzenearsonate,p Azobenzenearsonate,para Azobenzenearsonate
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross

Related Publications

M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
April 1979, Nature,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
April 1986, Journal of immunology (Baltimore, Md. : 1950),
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
August 1982, Surgery,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
June 1983, Annals of the New York Academy of Sciences,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
September 1980, Transplantation proceedings,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
January 1991, Microbiology and immunology,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
October 1989, Cellular immunology,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
September 1984, Cellular immunology,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
January 1986, The Journal of molecular and cellular immunology : JMCI,
M Takaoki, and M S Sy, and B Whitaker, and J Nepom, and R Finberg, and R N Germain, and A Nisonoff, and B Benacerraf, and M I Greene
December 1983, The Journal of experimental medicine,
Copied contents to your clipboard!